In my head, I always put them in a bucket with Theranos and uBeam, Startups who made product claims which experts in their fields said were not possible.
I guess slick marketing wins over those doubts in some VC circles but you wonder if anyone at the early stage Magic Leap investors is getting asked tough questions about why they approved it, or if they've all just moved on to other roles.
It's basically the only alternative for an investor who wants to get into AR, other than buying MSFT of AAPL stocks. That's why, despite shipping a V1 almost as good as the HoloLens V1 they are getting funded again.
Problem is, by the time Magic Leap gets it's V2 out there's a good chance we'll be seeing HoloLens V3 in the field.